As of 2026-03-31, 礼来 eli lilly's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 0.00%, below the industry average by 4.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 礼来 eli lilly's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
礼来 eli lilly's Mention Rate is 0.00%, lower than 0.6% of competitors
礼来 eli lilly's First Mention is 0.00%, lower than 0.9% of competitors
礼来 eli lilly's Preferred Rate is 0.00%, lower than 100.0% of competitors
礼来 eli lilly's Positive Rate is 0.00%, lower than 8.9% of competitors
礼来 eli lilly's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 云云南白药 | 22.92% | 2.08% | 0% | 20.83% | 2.08% | View Details |
| 以以岭药业 | 18.75% | 0% | 0% | 14.58% | 0% | View Details |
| 齐齐鲁制药 | 16.67% | 0% | 0% | 16.67% | 0% | View Details |
| 恒恒瑞医药 | 14.58% | 6.25% | 7.69% | 14.58% | 2.08% | View Details |
| 扬扬子江药业 | 12.5% | 2.08% | 0% | 12.5% | 0% | View Details |
| NNovo Nordisk | 4.17% | 0% | 0% | 4.17% | 2.08% | View Details |
| 礼礼来 eli lilly (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
